Shariat Moharari Reza, Valizade Ali, Najafi Atabak, Etezadi Farhad, Hosseini Seyed Reza, Khashayar Patricia, Khajavi Mohammad Reza, Mojtahedzadeh Mojtaba
Anesthesiology Department, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Associate professor of Urology, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Iran J Pharm Res. 2016 Spring;15(2):619-26.
Recently, the use of ketamine as a systemic and local analgesic drug in reducing post-operative pain is studied more frequently.
The aim of the present study was to assess the analgesic efficacy of IV ketamine injection inaddition to nephrostomy tract infiltration of ketamine-bupivacaine on postoperative pain relief after tubeless percutaneous nephrolithotomy (PCNL).
Patients (n = 100), with renal stone who were candidates for PCNL were randomized to five groups with 20 cases in each: Group C, 10 mL of saline solution was infiltrated into the nephrostomy tract; Group B, 10 mL of 0.25% bupivacaine was infiltrated into the nephrostomy tract; Group BK1, 10 mL of 0.25% bupivacaine plus 0.5 mg/kg ketamine was infiltrated into the nephrostomy tract; Group BK2, 10 mL of 0.25% bupivacaine plus 1.5 mg/kg ketamine was infiltrated into the nephrostomy tract; Group K, 10 mL of saline solution containing 0.5 mg/kg ketamine was intravenously administered. Post-operative pain scores were compared between groups as the primary objective. Comparison of Sedation Scores, rescue analgesic consumption, time to the first rescue analgesics administration, hemodynamic and SpO2 values were regarded as the secondary objective.
Mean VAS scores in the first 30 min and total analgesic consumption in the first 24 h of post-operative period were significantly lower in groups BK1 and BK2 in comparison with the other groups (P < 0.05). Also, time to first rescue analgesics administration was longer in the same groups (P < 0.05).
Infiltration of ketamine plus bupivacaine provides superior analgesic effects in PCNL surgery compared with other methods.
最近,氯胺酮作为一种全身和局部镇痛药用于减轻术后疼痛的研究越来越频繁。
本研究的目的是评估在无管经皮肾镜取石术(PCNL)后,静脉注射氯胺酮联合肾造瘘通道内注入氯胺酮-布比卡因对术后疼痛缓解的镇痛效果。
100例拟行PCNL的肾结石患者被随机分为五组,每组20例:C组,向肾造瘘通道内注入10 mL生理盐水;B组,向肾造瘘通道内注入10 mL 0.25%布比卡因;BK1组,向肾造瘘通道内注入10 mL 0.25%布比卡因加0.5 mg/kg氯胺酮;BK2组,向肾造瘘通道内注入10 mL 0.25%布比卡因加1.5 mg/kg氯胺酮;K组,静脉注射含0.5 mg/kg氯胺酮的10 mL生理盐水。将组间术后疼痛评分作为主要观察指标进行比较。镇静评分、补救性镇痛药用量、首次使用补救性镇痛药的时间、血流动力学及SpO2值的比较作为次要观察指标。
与其他组相比,BK1组和BK2组术后30分钟内的平均视觉模拟评分(VAS)及术后24小时内的总镇痛药用量显著更低(P<0.05)。同样,这两组首次使用补救性镇痛药的时间更长(P<0.05)。
与其他方法相比,氯胺酮联合布比卡因注入在PCNL手术中具有更好的镇痛效果。